Influence of CYP2C8*3 and ABCG2 C421A genetic polymorphisms on trough concentration and molecular response of imatinib in Egyptian patients with chronic myeloid leukemia. The gene discussed is ABCG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.